About us

We all need support through the most important period of our children: the early years

Aliquam rhoncus mauris, convallis volutpat velit bibendum dui duis ut vulputate amet, ac ipsum nisl convallis ut.

Pulvinar ultrices porta mattis quis lobortis est facilisis purus nunc, sed semper enim dictum sed donec condimentum sodales sed non vel malesuada morbi arcu justo, pretium sagittis hac nisi amet, fermentum nunc.

Blandit auctor felis habitasse aliquet est potenti ut urna eget orci pellentesque commodo vitae.

Founder & Head of School

Magna et nibh quam eu at viverra ut hac faucibus sed cras.

Felis mauris quisque scelerisque ac et, porta sit placerat pharetra, ac sodales vel vitae tincidunt mauris arcu placerat mi quis lorem orci, parturient rutrum.

Tortor platea nunc lorem morbi pellentesque sed enim viverra venenatis, sem pellentesque massa nunc quis lectus.

Yolanda Jenkins

Why it matters

By addressing this urgent medical need, LUMINATE contributes to healthier, more active lives, ensuring that patients regain mobility without the burden of chronic pain or invasive surgery.

• 2 million traumatic osteochondral injuries occur annually

• 50% of severe cases lead to PTOA within 10 years

• 12% of all osteoarthritis cases are due to traumatic injuries, significantly impacting quality of life

• Women account for 62% of total joint arthroplasties, indicating a strong gender bias in OA development.

Related Goals

Horizon Europe’s "Good Health & Well-being" (SDG 3)

Enhancing patient-centered healthcare

Improving treatment accessibility for a broader population

Economic: Reducing healthcare costs related to joint replacement surgeries

The economic burden of osteochondral injuries and osteoarthritis is immense, affecting healthcare systems, insurers, and patients alike. Current treatments, such as joint replacement surgeries, are not only invasive and costly but also lead to long-term expenses due to implant revisions and post-surgical care.

Financial Burden of OC Injuries & Arthritis:

Osteoarthritis costs €76 billion annually in Europe due to treatment, rehabilitation, and productivity loss

Each knee replacement surgery costs €12,000 on average, plus post-operative expenses

50% of younger patients (<50 years) require revision surgeries, doubling healthcare costs

LUMINATE introduces a cost-effective alternative:

pexels-photo-17485657.jpg
✔️ Single-stage bioprinting – Eliminating the need for multiple surgeries, reducing hospital stays and rehabilitation expenses

✔️ Preventing progression to osteoarthritis (OA) – By stopping OC injuries from worsening, LUMINATE significantly cuts long-term treatment costs

✔️ Less need for revision surgeries – Patients avoid expensive implant replacements, particularly younger individuals who face multiple interventions in their lifetime

✔️ Faster return to work – By enabling quicker recovery, patients experience less productivity loss, reducing the economic impact on employers and national healthcare systems

Market Growth & Job Creation

LUMINATE’s innovative bioprinting technology will create new opportunities in:

  • Biomedical engineering & 3D bioprinting industries – Developing high-tech medical devices.
  • Regenerative medicine & tissue engineering – Advancing research in biofabrication.
  • Orthopedic & surgical markets – Providing surgeons with new tools for advanced regenerative therapies.
What parent say
Faucibus nulla tincidunt sagittis faucibus proin habitasse nunc erat sed nisi non pulvinar at ante diam nulla tincidunt lectus maecenas penatibus nam suspendisse cursus risus, ac nibh suspendisse
Ramona Altenwerth

More than just a joyful place

Egestas pulvinar phasellus id odio viverra pharetra congue est eleifend aenean cras

Scroll to Top